Page last updated: 2024-10-29

staurosporine aglycone and Facial Pain

staurosporine aglycone has been researched along with Facial Pain in 1 studies

staurosporine aglycone: metabolite from culture broth of Nocardiopsis sp.; a neurotrophin antag; inhibits BDNF TrkB receptor

Facial Pain: Pain in the facial region including orofacial pain and craniofacial pain. Associated conditions include local inflammatory and neoplastic disorders and neuralgic syndromes involving the trigeminal, facial, and glossopharyngeal nerves. Conditions which feature recurrent or persistent facial pain as the primary manifestation of disease are referred to as FACIAL PAIN SYNDROMES.

Research Excerpts

ExcerptRelevanceReference
"CFA injection induced heat hyperalgesia of the ipsilateral whisker pad skin."1.37Nerve growth factor contribution via transient receptor potential vanilloid 1 to ectopic orofacial pain. ( Asano, M; Hitomi, S; Honda, K; Iwata, K; Katagiri, A; Omagari, D; Shinoda, M, 2011)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Shinoda, M1
Asano, M1
Omagari, D1
Honda, K1
Hitomi, S1
Katagiri, A1
Iwata, K1

Other Studies

1 other study available for staurosporine aglycone and Facial Pain

ArticleYear
Nerve growth factor contribution via transient receptor potential vanilloid 1 to ectopic orofacial pain.
    The Journal of neuroscience : the official journal of the Society for Neuroscience, 2011, May-11, Volume: 31, Issue:19

    Topics: Analysis of Variance; Animals; Antibodies, Neutralizing; Behavior, Animal; Blotting, Western; Carbaz

2011